Market Size, Competition Pattern and Future Development Forecast of China Animal Vaccine Market in 2016

 Published On: Feb, 2017 |  Published By: Beijing Orient Agribusiness Consultant Ltd | Format: PDF
Request Free Sample
Research Background

Since 2003, with the rapid development of livestock and poultry breeding industry and the implementation of compulsory immunization policy for major animal diseases, China’s market size of animal vaccine has seen rapid growth, the sales value of domestic and foreign manufacturers has increased to 1.4 billion yuan in 2015 from about 3 million yuan, reaching a compound growth rate of 15.1%, of which, hog and poultry vaccine accounted for 81.4% of total sales value.

China’s market size of animal vaccine will maintain stable growth in next ten years, BOABC makes following analyses:
First, vaccine cost for unit livestock and poultry will rise up, which will drive China’s market size of animal vaccine up smoothly. China will speed up transformation and upgrading of livestock and poultry production mode, though total breeding quantity will grow at low speed, the scale level and market share of large groups will increase rapidly, the use of vaccine in productive process will be more scientific and standard.

Second, vaccine products of different classes have greater potential, especially high-end vaccine. Taking swine vaccine for example, the penetration ratio of commercial PVC2 vaccine and FMD vaccine respectively is less than 35% and 15%, future market potential is great, at the same time, scale farms’ demand for high-end products will increase further. In addition, market potential of PRV, diarrhea, M.Hyo. and other products will be released gradually.

Third, compulsory immunization policy adjustment stimulates the growth of animal vaccine market size. China temporarily stop implementing national unified tender for purchasing CSF and PRRS vaccine in 2016, as compulsory product the price difference between commercial CSF vaccine and tender CSF vaccine is more than five times, the market size of CSF vaccine will expand gradually. At the same time, brucellosis and CE vaccine are included in the scope of compulsory immunization, and government tendering procurement will drive the growth of market size of these two products.

However, with the improvement of R&D capacity and mature of productive technology of China’s animal biological product enterprises, the competition of this industry is becoming fierce increasingly, it becomes particular critical that how enterprises make proper development strategy to make them obtain leading advantages in cruel market competition. Facing with this condition, it becomes more important to learn and grasp the development situation and trend of this industry. For example, how to grasp the trend of national policies and regulations for this industry? How about the competition pattern and trend? How about the market size and development potential of different vaccine products? How about the characteristics of different disease vaccines? How about the demand of customers? How about the R&D direction of new products and operation situation of major domestic competitors?

The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation of domestic and foreign vaccine enterprises and future development trend of China’s animal biological product industry on the basis of stating current situation of the industry in 2015 so as to make comprehensive organization and judgment on the competition situation and development trend of China’s animal vaccine industry and assist manufacturers and investment organization to better grasp the development course of China’s animal vaccine industry. 

This report is written elaborately based on the data from national level authoritative departments including the National Bureau of Statistics, General Administration of Customs , the MOA, China Institute of Veterinary Drug Control, China Veterinary Drug Association, China Animal Agricultural Association and industrial associations, the data are accurate and authoritative, moreover, this report integrates the views of experts, having high scientificity and prospectiveness. BOABC believes that the report is an important reference material for domestic and foreign animal vaccine manufacturers, investors, associations and research organizations to make strategic decision     This report is written elaborately based on the data from national level authoritative departments including the National Bureau of Statistics, General Administration of Customs , the MOA, China Institute of Veterinary Drug Control, China Veterinary Drug Association, China Animal Agricultural Association and industrial associations, the data are accurate and authoritative, moreover, this report integrates the views of experts, having high scientificity and prospectiveness. BOABC believes that the report is an important reference material for domestic and foreign animal vaccine manufacturers, investors, associations and research organizations to make strategic decision
Chapter One Development Course and Policy Environment of China’s Animal Vaccine Industry
1.1 Development course of China’s animal vaccine industry
1.2 Position and share of animal vaccine in China’s animal health product industry
1.3 Comparison between global and Chinese animal vaccine industry
1.4 Policy environment of China’s animal vaccine industry
1.4.1 “National Mid-and-long Term Plan for Animal Diseases Control”
1.4.2 China’s production policy for animal vaccine industry
1.4.3 Influence of compulsory immunization policy adjustment on China’s animal vaccine industry
1.4.4 China’s circulation policy for animal vaccine industry
1.4.5 China’s trade policy for animal vaccine industry
1.5 Development direction of China’s animal vaccine industry
Chapter Two China’s Market Size of Animal Vaccine Industry in 2015Market size of China’s animal vaccine market
2.1 China’s market size of animal vaccine market
2.1.1 Market size of domestic vaccine
2.1.2 Market size of foreign vaccine
2.2 China’s Market size of swine vaccine
2.2.1 China swine diseases epidemic situation analysis
2.2.2 China’s market size of swine vaccine
2.2.3 Market size of main swine vaccines
2.2.3.1 Market size and product features of FMD vaccine
2.2.3.2 Market size and product features of CSF vaccine
2.2.3.3 Market size and product features of PRRS vaccine
2.2.3.4 Market size and product features of PRV vaccine
2.2.3.5 Market size and product features of PCV2 vaccine
2.2.3.6 Market size of other vaccines
2.2.4 Market concentration of top 10 swine vaccine enterprises in China
2.3 China’s market size of poultry vaccine
2.3.1 China poultry diseases epidemic situation analysis
2.3.2 China’s market size of poultry vaccine
2.3.3 Market size of main poultry vaccines
2.3.3.1 Market size and product features of H5N1 vaccine
2.3.3.2 Market size and product features of ND vaccine
2.3.3.3 Market size and product features of MD vaccine
2.3.3.4 Market size and product features of IBD vaccine
2.3.3.5 Market size and product features of IB vaccine
2.3.3.6 Market size of other vaccines
2.3.4 Market concentration of top 10 poultry vaccine enterprises in China
2.4 China’s market size of ruminant vaccine
2.4.1 China’s ruminant diseases epidemic situation analysis
2.4.2 China’s market size of ruminant vaccine
2.4.3 Market size of main ruminant vaccines
2.4.3.1 Market size and product features of FMD vaccine
2.4.3.2 Market size and product features of brucellosis vaccine
2.4.3.3 Market size and product features of PPR vaccine
2.4.3.4 Market size of other vaccines
2.4.4 Market concentration of ruminant vaccine industry in China
2.5 China’s market size of other animal vaccines
Chapter Three Development Trend of China’s Animal Vaccine Industry
3.1 Change trend of swine vaccine market size
3.1.1 Vaccine expense analysis of pig farms of different sizes
3.1.2 China’s breeding quantity of pigs in next decade
3.1.3 China’s scale level of pig breeding in next decade
3.1.4 Forecast on growth of market size of swine vaccine in next decade
3.2 Change trend of poultry vaccine market size
3.2.1 Vaccine expense analysis of chicken farms of different sizes
3.2.2 China’s breeding quantity of poultry in next decade
3.2.3 China’s scale level of poultry breeding in next decade
3.2.4 Forecast on growth of market size of poultry vaccine in next decade
3.3 Change trend of market size of other vaccines
3.3.1 Forecast on growth of market size of ruminant vaccine in next decade
3.3.2 Forecast on growth of market size of aquatic vaccine in next decade
3.3.3 Forecast on growth of market size of pet vaccine in next decade
Chapter Four Analysis of Industrial Chain of China’s Animal Vaccine Industry
4.1 R&D link
4.1.1  Main research institutions of China’s animal vaccine industry
4.1.2  Technology research and development mode of China’s animal vaccine industry
4.1.3  Technology research and development capacity of China’s animal vaccine industry
4.1.4  Summary of technology transfer of China’s main animal vaccines (research unit, transfer price and acceptor)
4.2 Production link
4.2.1  Number of animal vaccine enterprises in China
4.2.2  Capacity and output value of animal vaccine enterprises in China
4.2.3  Analysis of gross profit rate of China’s animal vaccine industry
4.2.4  Price analysis of China’s main animal vaccine products
4.2.5  Analysis of market concentration of China’s animal vaccine industry
4.3 Circulation link
4.3.1  Circulation ways of animal vaccine in China
4.3.2  Analysis of distribution channel of animal vaccine in China
4.3.3  Analysis of profit of animal vaccine dealers in China
4.3.4  Change trend of distribution channel of animal vaccine in China
Chapter Five Analysis of Main Animal Vaccine Enterprises in China
5.1 CAHIC
5.1.1 Company profile
5.1.2 Vaccine product mix
5.1.3 Animal vaccine sales revenue
5.1.4 Forecast on performance growth in next five years
5.2 JINYU BIO-TECHNOLOGY CO., LTD.
5.2.1 Company profile
5.2.2 Vaccine product mix
5.2.3 Animal vaccine sales revenue
5.2.4 Forecast on performance growth in next five years
5.3 PULIKE
5.3.1 Company profile
5.3.2 Vaccine product mix
5.3.3 Animal vaccine sales revenue
5.3.4 Forecast on performance growth in next five years
5.4 HILE
5.4.1 Company profile
5.4.2 Vaccine product mix
5.4.3 Animal vaccine sales revenue
5.4.4 Forecast on performance growth in next five years
5.5 Tianjin Ringpu
5.5.1 Company profile
5.5.2 Vaccine product mix
5.5.3 Animal vaccine sales revenue
5.5.4 Forecast on performance growth in next five years
5.6 CHOPPER
5.6.1 Company profile
5.6.2 Vaccine product mix
5.6.3 Animal vaccine sales revenue
5.6.4 Forecast on performance growth in next five years
5.7 TECON
5.7.1 Company profile
5.7.2 Vaccine product mix
5.7.3 Animal vaccine sales revenue
5.7.4 Forecast on performance growth in next five years
5.8 WINSUN
5.8.1 Company profile
5.8.2 Vaccine product mix
5.8.3 Animal vaccine sales revenue
5.8.4 Forecast on performance growth in next five years
5.9 CHINA AGRICULTURAL VET.BIO.SCIENCE and TECHNOLOGY CO., LTD. 
5.9.1 Company profile
5.9.2 Vaccine product mix
5.9.3 Animal vaccine sales revenue
5.9.4 Forecast on performance growth in next five years
5.10 JILIN ZHENGYE BIOLOGICAL CO., LTD.
5.10.1 Company profile
5.10.2 Vaccine product mix
5.10.3 Animal vaccine sales revenue
5.10.4 Forecast on performance growth in next five years
Chapter Six Analysis of Main Foreign Animal Vaccine Enterprises
6.1 Boehringer Ingelheim
6.1.1 Company profile
6.1.2 Vaccine product mix
6.1.3 Animal vaccine sales revenue
6.1.4 Forecast on performance growth in next five years
6.2 ZOETIS
6.2.1 Company profile
6.2.2 Vaccine product mix
6.2.3 Animal vaccine sales revenue
6.2.4 Forecast on performance growth in next five years
6.3 Merial
6.3.1 Company profile
6.3.2 Vaccine product mix
6.3.3 Animal vaccine sales revenue
6.3.4 Forecast on performance growth in next five years
6.4 HIPRA
6.4.1 Company profile
6.4.2 Vaccine product mix
6.4.3 Animal vaccine sales revenue
6.4.4 Forecast on performance growth in next five years
6.5 MSD
6.5.1 Company profile
6.5.2 Vaccine product mix
6.5.3 Animal vaccine sales revenue
6.5.4 Forecast on performance growth in next five years
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.